NeuroPace, Inc.
NPCE
$8.42
-$0.14-1.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.52M | 22.52M | 21.47M | 21.06M | 19.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.52M | 22.52M | 21.47M | 21.06M | 19.26M |
| Cost of Revenue | 5.39M | 5.18M | 5.28M | 5.64M | 5.12M |
| Gross Profit | 18.13M | 17.34M | 16.19M | 15.42M | 14.13M |
| SG&A Expenses | 18.11M | 15.05M | 13.79M | 13.91M | 14.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.34M | 27.67M | 25.12M | 25.30M | 25.49M |
| Operating Income | -6.82M | -5.15M | -3.65M | -4.24M | -6.23M |
| Income Before Tax | -8.65M | -6.59M | -5.25M | -5.45M | -7.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.65M | -6.59M | -5.25M | -5.45M | -7.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.65M | -6.59M | -5.25M | -5.45M | -7.51M |
| EBIT | -6.82M | -5.15M | -3.65M | -4.24M | -6.23M |
| EBITDA | -6.77M | -5.10M | -3.61M | -4.19M | -6.17M |
| EPS Basic | -0.26 | -0.21 | -0.18 | -0.19 | -0.26 |
| Normalized Basic EPS | -0.16 | -0.13 | -0.11 | -0.12 | -0.16 |
| EPS Diluted | -0.26 | -0.21 | -0.18 | -0.19 | -0.26 |
| Normalized Diluted EPS | -0.16 | -0.13 | -0.11 | -0.12 | -0.16 |
| Average Basic Shares Outstanding | 32.86M | 31.48M | 29.91M | 29.44M | 28.85M |
| Average Diluted Shares Outstanding | 32.86M | 31.48M | 29.91M | 29.44M | 28.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |